Abstract
Amiodarone is one of the most commonly prescribed antiarrhythmic drug for almost all atrial or ventricular arrythmias. Amiodarone-induced pulmonary toxicity (APT) was first described in 1980 and has potentially serious side effects that are believed to develop in 5% of patients. In general, APT occurs only when high amiodarone doses are used for a long time. However, during short-term therapy of amiodarone, APT is rarely reported. In this report, we describe a case of amiodarone-induced pulmonary toxicity after a short course of amiodarone therapy for atrial fibrillation.
Citations
Citations to this article as recorded by
- A Case of Acute Hepatitis Associated with Intravenous Infusion Amiodarone in Patient with Atrial Fibrillation
Ji Hye Lee, Myug-Shin Kang, Tae-Hoon Kim, Dong Hee Shin, Rak Kyeong Choi, Su Jin Jung
Soonchunhyang Medical Science.2015; 21(2): 208. CrossRef - Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation
Dae Jung Kim, Sang Chil Lee, Gi Soo Park, Gyung Jung Kim, Won Tae Hwang, Chang Soo Lee, Moo Hyun Lee, Dae Hee Hahn, Hyeon Cheol Koh
Journal of the Korean Geriatrics Society.2013; 17(4): 223. CrossRef - Very Early Onset of Amiodarone-Induced Pulmonary Toxicity
Wonho Lee, Dong Rueol Ryu, Seon-Sook Han, Sook-Won Ryu, Byung Ryul Cho, Hyucki Kwon, Bo Ra Kim
Korean Circulation Journal.2013; 43(10): 699. CrossRef - Amiodarone-Induced Pulmonary Toxicity: Percutaneous Needle Aspiration Biopsy and Ultrastructural Findings
In Sook Kang, Jin Hwa Lee, Sun Hee Sung, Seong Hoon Park
The Ewha Medical Journal.2013; 36(2): 144. CrossRef